NCT07650071

Brief Summary

Abortion is a fundamental right for women in France, where the legal time limit was extended from 14 to 16 weeks' gestation. This extension allows women, whose psychosocial determinants are poorly known, and who face various obstacles (personal, administrative, medical, or other), to access abortion. However, it may also expose them to psychological troubles and difficulties in accessing healthcare. This study aims to identify the psychosocial determinants and disruptions in the primary care pathway associated with late abortions (≥14 weeks' gestation \[WG\]) in order to propose preventive actions, particularly regarding contraception, screening, and referral, directly applicable in general practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Jun 2026Sep 2027

First Submitted

Initial submission to the registry

June 10, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

June 15, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2027

Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

1 year

First QC Date

June 10, 2026

Last Update Submit

June 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Describe the sociodemographic profile of patients undergoing late-term abortion at Avignon Hospital.

    Inclusion

Secondary Outcomes (10)

  • Proportion of patients who attended the hospital for a late-term abortion following a general practitioner's recommendation.

    Inclusion

  • Proportion of patients who involved their general practitioner in the care pathway for late-term abortions.

    Inclusion

  • Descriptive analysis of patients' medical follow-up, medical history and contraceptive practices.

    Inclusion

  • Frequency of reasons leading to pregnancy and circumstances of pregnancy discovery.

    Inclusion

  • Descriptive analysis of patients' relationships with their entourage regarding this pregnancy (partner, family, healthcare professionals, etc.).

    Inclusion

  • +5 more secondary outcomes

Study Arms (1)

Health survey

EXPERIMENTAL

This is a health survey. Following patient recruitment, the physician will explain the study and its objectives. If the patient agrees to participate, a QR code will be provided to allow anonymous access to the study questionnaire. The patient will be invited to complete the questionnaire after the medical consultation.

Behavioral: Health survey

Interventions

Health surveyBEHAVIORAL

It consists of a single anonymous questionnaire, to be completed once only, on a secure online platform, accessed using a QR code provided directly by the healthcare professional. The questionnaire consists of 39 main questions, predominantly with closed-ended response options. The average completion time is estimated between 10 and 20 minutes.

Health survey

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged ≥ 18 years
  • Pregnancy ≥ 14 weeks' gestation
  • Patient attending Avignon Hospital for a surgical abortion
  • Willing to participate in the study

You may not qualify if:

  • Medical abortion (non-surgical means of abortion)
  • Ectopic pregnancy
  • Inability to complete the questionnaire
  • Patients under legal protection measures (guardianship, curatorship, or court-ordered protection)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier d'Avignon, Hôpital Henri Duffaut

Avignon, 84000, France

Location

MeSH Terms

Interventions

Health Surveys

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Perrine Mazet, MD

    Centre Hospitalier d'Avignon, Service de Gynécologie

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 16, 2026

Study Start

June 15, 2026

Primary Completion (Estimated)

June 15, 2027

Study Completion (Estimated)

September 15, 2027

Last Updated

June 16, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations